Human Molecular Genetics Advance Access published online on November 8, 2005
Human Molecular Genetics, doi:10.1093/hmg/ddi413
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Neurodegeneration Research Lab, National Neuroscience Institute, Singapore; Departments of Biological Sciences, National University of Singapore, Singapore
* To whom correspondence should be addressed. Mutations in parkin are currently recognized as the most common cause of familial Parkinsonism. Emerging evidence also suggest that parkin expression variability may confer a risk for the development of the more common, sporadic form, of Parkinson's disease (PD). Supporting this, we have recently demonstrated that parkin solubility in the human brain becomes altered with age. Since parkin apparently functions as a broad-spectrum neuroprotectant, the resulting decrease in the availability of soluble parkin with age may underlie the progressive susceptibility of the brain to stress. Interestingly, we also observed that many familial-PD mutations of parkin alter its solubility in a manner that is highly reminiscent of our observations with the aged brain. The converging effects on parkin brought about by aging and PD-causing mutations are probably not trivial, and suggest that environmental modulators affecting parkin solubility would increase an individual's risk of developing PD. Using both cell culture and in-vivo models, we demonstrate here that several PD-linked stressors, including neurotoxins (MPP+, Rotenone, 6-OHDA), paraquat, NO, dopamine and iron, induce alterations in parkin solubility and result in its intracellular aggregation. Furthermore, the depletion of soluble, functional forms of parkin is associated with reduced proteasomal activities and increased cell death. Our results suggest that exogenously introduced stress as well as endogenous dopamine could affect the native structure of parkin, promote its misfolding, and concomitantly compromise its protective functions. Mechanistically, our results provide a link between the influence of environmental and intrinsic factors and genetic susceptibilities in PD pathogenesis.
Received September 21, 2005
Accepted November 2, 2005
Article
Stress-induced Alterations in Parkin Solubility Promote Parkin Aggregation and Compromise Parkin's Protective Function
2 Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Departments of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
3 Departments of Physiology, National University of Singapore, Singapore
4 Neurodegeneration Research Lab, National Neuroscience Institute, Singapore
5 Departments of Biological Sciences, National University of Singapore, Singapore
6 Departments of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
7 Departments of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Departments of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
8 Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Departments of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Departments of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA
9 Neurodegeneration Research Laboratory, National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore 308433; Departments of Biological Sciences, National University of Singapore, Singapore
Kah-Leong Lim, E-mail: Kah_Leong_Lim{at}nni.com.sg
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. K. Berger, G. P. Cortese, K. D. Amodeo, A. Weihofen, A. Letai, and M. J. LaVoie Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release Hum. Mol. Genet., November 15, 2009; 18(22): 4317 - 4328. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Ng, S. Z. S. Mok, C. Koh, X. Ouyang, M. L. Fivaz, E.-K. Tan, V. L. Dawson, T. M. Dawson, F. Yu, and K.-L. Lim Parkin Protects against LRRK2 G2019S Mutant-Induced Dopaminergic Neurodegeneration in Drosophila J. Neurosci., September 9, 2009; 29(36): 11257 - 11262. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rubio de la Torre, B. Luzon-Toro, I. Forte-Lago, A. Minguez-Castellanos, I. Ferrer, and S. Hilfiker Combined kinase inhibition modulates parkin inactivation Hum. Mol. Genet., March 1, 2009; 18(5): 809 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-H. Lu, S. M. Fleming, B. Meurers, L. C. Ackerson, F. Mortazavi, V. Lo, D. Hernandez, D. Sulzer, G. R. Jackson, N. T. Maidment, et al. Bacterial Artificial Chromosome Transgenic Mice Expressing a Truncated Mutant Parkin Exhibit Age-Dependent Hypokinetic Motor Deficits, Dopaminergic Neuron Degeneration, and Accumulation of Proteinase K-Resistant {alpha}-Synuclein J. Neurosci., February 18, 2009; 29(7): 1962 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Schlehe, A. K. Lutz, A. Pilsl, K. Lammermann, K. Grgur, I. H. Henn, J. Tatzelt, and K. F. Winklhofer Aberrant Folding of Pathogenic Parkin Mutants: AGGREGATION VERSUS DEGRADATION J. Biol. Chem., May 16, 2008; 283(20): 13771 - 13779. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kawahara, M. Hashimoto, P. Bar-On, G. J. Ho, L. Crews, H. Mizuno, E. Rockenstein, S. Z. Imam, and E. Masliah {alpha}-Synuclein Aggregates Interfere with Parkin Solubility and Distribution: ROLE IN THE PATHOGENESIS OF PARKINSON DISEASE J. Biol. Chem., March 14, 2008; 283(11): 6979 - 6987. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M.M. Tan, E. S.P. Wong, D. S. Kirkpatrick, O. Pletnikova, H. S. Ko, S.-P. Tay, M. W.L. Ho, J. Troncoso, S. P. Gygi, M. K. Lee, et al. Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases Hum. Mol. Genet., February 1, 2008; 17(3): 431 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Thomas and M. F. Beal Parkinson's disease Hum. Mol. Genet., October 15, 2007; 16(R2): R183 - R194. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang, R. Lu, X. Ouyang, M. W. L. Ho, W. Chia, F. Yu, and K.-L. Lim Drosophila Overexpressing Parkin R275W Mutant Exhibits Dopaminergic Neuron Degeneration and Mitochondrial Abnormalities J. Neurosci., August 8, 2007; 27(32): 8563 - 8570. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Avraham, R. Rott, E. Liani, R. Szargel, and S. Engelender Phosphorylation of Parkin by the Cyclin-dependent Kinase 5 at the Linker Region Modulates Its Ubiquitin-Ligase Activity and Aggregation J. Biol. Chem., April 27, 2007; 282(17): 12842 - 12850. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. P. Wong, J. M. M. Tan, C. Wang, Z. Zhang, S.-P. Tay, N. Zaiden, H. S. Ko, V. L. Dawson, T. M. Dawson, and K.-L. Lim Relative Sensitivity of Parkin and Other Cysteine-containing Enzymes to Stress-induced Solubility Alterations J. Biol. Chem., April 20, 2007; 282(16): 12310 - 12318. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. H. Henn, L. Bouman, J. S. Schlehe, A. Schlierf, J. E. Schramm, E. Wegener, K. Nakaso, C. Culmsee, B. Berninger, D. Krappmann, et al. Parkin Mediates Neuroprotection through Activation of I{kappa}B Kinase/Nuclear Factor-{kappa}B Signaling J. Neurosci., February 21, 2007; 27(8): 1868 - 1878. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-K. Sang, H.-Y. Chang, G. M. Lawless, A. Ratnaparkhi, L. Mee, L. C. Ackerson, N. T. Maidment, D. E. Krantz, and G. R. Jackson A Drosophila Model of Mutant Human Parkin-Induced Toxicity Demonstrates Selective Loss of Dopaminergic Neurons and Dependence on Cellular Dopamine J. Neurosci., January 31, 2007; 27(5): 981 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hampe, H. Ardila-Osorio, M. Fournier, A. Brice, and O. Corti Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity Hum. Mol. Genet., July 1, 2006; 15(13): 2059 - 2075. [Abstract] [Full Text] [PDF] |
||||


